Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus

The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health. Vaccines are ideal solutions to prevent infection, but treatments are also needed for those who have contracted the virus to limit negative outcomes, when vaccin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Biol Chem
Autors principals: Vitner, Einat B., Achdout, Hagit, Avraham, Roy, Politi, Boaz, Cherry, Lilach, Tamir, Hadas, Yahalom-Ronen, Yfat, Paran, Nir, Melamed, Sharon, Erez, Noam, Israely, Tomer
Format: Artigo
Idioma:Inglês
Publicat: American Society for Biochemistry and Molecular Biology 2021
Matèries:
Accelerated Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904475/
https://ncbi.nlm.nih.gov/pubmed/33639165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbc.2021.100470
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars